[Editorial] Making Ayurveda a Real Science

This page is locked for members only!

Login below if you're already a member.

Related Articles

AYUSH Sector in India – Objectives, Scope, Challenges, Way Forward

The Covid-19 pandemic has brought the spotlight on the health-promoting and disease-preventive solutions of Ayush disciplines. Recently, the operational integration of Ayush Grid, the emerging IT backbone for AYUSH Sector with the National Digital Health Mission (NDHM), was endorsed at a high-level meeting. This integration will be immensely beneficial to the public for availing varied options for their health needs. The integration will also accelerate the mainstreaming of the AYUSH disciplines of healthcare.

Clinical Trials in India – Conflict between Public Health Vs Safety

The New Drugs and Clinical Trial Rules, 2019 released by the government seeks to enable faster approvals and to cut down on red tape with respect to the clinical trials in India. It seeks to promote clinical research in India by providing for a predictable, transparent and effective regulation for clinical trials and by guaranteeing faster accessibility of new drugs to the Indian population. Thus it has the potential to reinvigorate the clinical research industry, which was almost on its death bed a few years ago.

This article answers the following questions in an analytical manner.

  1. What are clinical trials?
  2. What is the need for clinical trials?
  3. How Clinical trials are conducted?
  4. Why is India a popular destination for Clinical trials?
  5. What is the regulatory mechanism for Clinical Trials in India?
  6. What are the key Issues regarding Clinical Trials in India?
  7. What are the measures taken by the government to solve those issues?
  8. What are the features and significances of the new rules of 2019?
  9. What are the suggestions to further improve the scenario?

Herd Immunity During Coronavirus Pandemic – Issues And Drawbacks

UK government is currently facing criticism for implementing “targeted herd immunity” during the early stages of the coronavirus outbreak in the country. This strategy involves allowing people to be infected so that they can gain immunity. The government was forced to abandon this controversial strategy after seeing an increase in pressure on the country’s healthcare system. Now, the death toll has surpassed 30,000 due to COVID-19 in the UK. The World Health Organisation has warned that herd immunity strategy is experimental at best and dangerous at worst. Yet, some experts in India are also considering this strategy as a way to reduce the problems faced by the economy, which is suffering because of the coronavirus pandemic.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x